$106 Million is the total value of Data Collective IV GP, LLC's 5 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | Evolv Technologies Holdings, Inc. | $47,051,023 | -26.0% | 9,681,280 | -8.7% | 44.52% | -5.5% | |
| RXRX | Recursion Pharmaceuticals, Inc.cl a | $45,449,568 | +2.4% | 5,941,120 | 0.0% | 43.00% | +30.9% | |
| Rocket Lab USA, Inc. | $12,830,553 | -27.0% | 2,929,350 | 0.0% | 12.14% | -6.7% | ||
| Sell | Mind Medicine (MindMed) Inc. | $314,095 | -12.3% | 100,349 | -0.0% | 0.30% | +12.1% | |
| Roivant Sciences Ltd. | $45,260 | +15.9% | 3,875 | 0.0% | 0.04% | +48.3% | ||
| Exit | Embark Technology, Inc. | $0 | – | -3,186,007 | -100.0% | -6.75% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. | 8 | Q3 2023 | 50.0% |
| Evolv Technologies Holdings, Inc. | 8 | Q3 2023 | 47.1% |
| Rocket Lab USA, Inc. | 5 | Q4 2022 | 11.6% |
| Mind Medicine (MindMed) Inc. | 5 | Q4 2022 | 4.1% |
| Embark Trucks, Inc. | 4 | Q2 2023 | 18.7% |
| Roivant Sciences Ltd. | 4 | Q3 2023 | 0.2% |
| Embark Trucks, Inc. | 3 | Q2 2022 | 79.7% |
| Rocket Lab USA, Inc. | 3 | Q3 2023 | 13.0% |
| Mind Medicine (MindMed) Inc. | 3 | Q3 2023 | 0.3% |
View Data Collective IV GP, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-11-14 |
| 4 | 2022-09-01 |
View Data Collective IV GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.